RadNet, Inc. (FRA:PQIA)
Germany · Delayed Price · Currency is EUR | Market Cap | 4.19B +10.8% |
| Revenue (ttm) | 1.86B +14.7% |
| Net Income | -12.31M |
| EPS | -0.16 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 83.83 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 51.20 |
| Previous Close | 50.74 |
| Day's Range | 51.20 - 51.20 |
| 52-Week Range | 43.85 - 74.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 7, 2026 |
About RadNet
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store... [Read more]
News
RadNet’s DeepHealth receives two FDA clearances
DeepHealth, a wholly owned subsidiary of RadNet (RDNT), announces it has received FDA 510(k) clearances for two new Breast Suite functionalities: Breast Arterial Calcification Assessment, a tool appli...
DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite
SOMERVILLE, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), announces it has received...
RadNet Secures $250 Million Incremental Term Loan to Fund Strategic Growth Opportunities and Reduces the Interest Rates on its Credit Facility by 0.25%
LOS ANGELES, June 10, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services th...
DeepHealth Launches Reporting Pro, Bringing AI Automation to Radiology Reporting
SOMERVILLE, Mass., June 10, 2026 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced t...
RadNet Announces a Proposed $200 Million Incremental Term Loan to Fund Strategic Growth Opportunities
LOS ANGELES, June 03, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services th...
RadNet to Host Men's Health Webinar on June 13, 2026
RadNet hosts free webinar for Men's Health Month, featuring live Q&A and physicians presenting on coronary artery disease, prostate cancer and lung cancer.
RadNet price target lowered to $65 from $70 at Barclays
Barclays analyst Andrew Mok lowered the firm’s price target on RadNet (RDNT) to $65 from $70 and keeps an Overweight rating on the shares. The firm says RadNet is outperforming…
Amazon among seven added to Jefferies’ Franchise Picks list
Jefferies analysts added Amazon.com (AMZN), AppLovin (APP), Credo Technology (CRDO), McDonald’s (MCD), RadNet (RDNT), Thermo Fisher (TMO) and UL Solutions (ULS) to Jefferies’ Franchise Picks list, whi...
RadNet Earnings Call Transcript: Q1 2026
Record Q1 revenue and EBITDA were achieved despite weather impacts, driven by advanced imaging growth, strong Digital Health momentum, and successful acquisitions. Guidance for 2026 was raised, with robust cash flow and margin improvements expected as integration and AI deployment continue.
RadNet Earnings release: Q1 2026
RadNet released its Q1 2026 earnings on May 11, 2026, summarizing the period's financial results.
RadNet Quarterly report: Q1 2026
RadNet has published its Q1 2026 quarterly earnings report on May 11, 2026.
RadNet Reports Record First Quarter Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow
LOS ANGELES, May 10, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a netw...
RadNet price target lowered to $83 from $87 at B. Riley
B. Riley lowered the firm’s price target on RadNet (RDNT) to $83 from $87 and keeps a Buy rating on the shares. The Q1 reports across the radiotherapeutics and imaging…
RadNet forms joint venture with Saint Alphonsus Health System
RadNet (RDNT) announced the formation of a joint venture with Saint Alphonsus Health System through the acquisition of a majority equity position in Intermountain Medical Imaging, the owner of five…
RadNet and Trinity Health's Saint Alphonsus Health System Launch a Multi-Site Joint Venture in Boise, Idaho, to Include a Broad Technology Deployment of DeepHealth Solutions
RadNet forms joint venture with Saint Alphonsus Health System in Idaho, expanding its footprint and deploying DeepHealth OS to transform radiology workflow
RadNet, Inc. Announces Date of its First Quarter 2026 Financial Results Conference Call
LOS ANGELES, April 28, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, annou...
RadNet management to meet with KeyBanc
Meeting to be held in New York on April 27 hosted by KeyBanc.
RadNet Proxy statement: Proxy filing
RadNet filed a proxy statement on April 20, 2026, providing details for shareholder voting and corporate governance matters.
RadNet Proxy statement: Proxy filing
RadNet filed a proxy statement on April 20, 2026, providing details for shareholder voting and corporate governance matters.
GE HealthCare expands mammography collaboration with DeepHealth
GE HealthCare (GEHC) announced an expanded collaboration with DeepHealth, a player in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (RDNT), to further the innovation, com...
GE HealthCare expands mammography collaboration with RadNet's DeepHealth subsidiary to extend global access to DeepHealth's AI-powered breast cancer screening solutions
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an expanded collaboration with DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary o...
RadNet Transcript: 2026 KeyBanc Capital Markets Healthcare Forum
Strong growth in advanced imaging and digital health, driven by acquisitions, technology upgrades, and AI innovation, is expected to continue in 2026. Hospital joint ventures and regulatory trends support expansion, while the Gleamer acquisition positions the company as a global AI leader.
RadNet Transcript: Barclays 28th Annual Global Healthcare Conference
Record revenue and margin growth were highlighted, with strong MRI and PET CT volumes and a positive 2026 outlook. Digital health is set for over 50% growth, driven by acquisitions like Gleamer, which expands AI capabilities and synergies. Labor efficiencies and advanced imaging trends support sustained margin improvement.
RadNet Transcript: M&A announcement
The acquisition of Gleamer adds advanced X-ray AI capabilities, accelerating global expansion and automated reporting initiatives. Significant cost and revenue synergies are expected, with rapid integration and deployment planned for 2024. Break-even is targeted by mid-2027.